Naltrexone is recommended as a treatment option for people who have been opioid dependent but who have stopped using opioids, and who are highly motivated to stay free from the drugs in an abstinence programme.
It should only be given to people who have been told about the problems associated with treatment, and with proper supervision. Treatment with naltrexone should be given as part of a support programme to help the person manage their opioid dependence.
Healthcare professionals should regularly review how well naltrexone is working to help people stay off opioids. If there is evidence that the person has been using the drugs again then healthcare professionals should consider stopping naltrexone treatment.
Click here for the full artical.
Thursday 11 March 2010
Drug misuse - methadone and buprenorphine
Methadone and buprenorphine (given as a tablet or a liquid) are recommended as treatment options for people who are opioid dependent.
A decision about which is the better treatment should be made on an individual basis, in consultation with the person, taking into account the possible benefits and risks of each treatment for that particular person. If both drugs are likely to have the same benefits and risks, methadone should be given as the first choice.
Different people will need different doses of methadone or buprenorphine. People should take methadone or buprenorphine daily in the presence of their doctor, nurse or community pharmacist for at least the first 3 months of treatment and until they are able to continue their treatment correctly without supervision.
Treatment with methadone or buprenorphine should be given as part of a support programme to help the person manage their opioid dependence
Click Here to be taken to the full artical.
A decision about which is the better treatment should be made on an individual basis, in consultation with the person, taking into account the possible benefits and risks of each treatment for that particular person. If both drugs are likely to have the same benefits and risks, methadone should be given as the first choice.
Different people will need different doses of methadone or buprenorphine. People should take methadone or buprenorphine daily in the presence of their doctor, nurse or community pharmacist for at least the first 3 months of treatment and until they are able to continue their treatment correctly without supervision.
Treatment with methadone or buprenorphine should be given as part of a support programme to help the person manage their opioid dependence
Click Here to be taken to the full artical.
Presentations from the RMC
Please find below the links to the Presentations from the various Regional Master Classes.
Nat's Presentation
How To Read an Academic Paper
Linda's Manchester RMC presentation
Gordon's Presentation
Steve's Presentation
Nat's Presentation
How To Read an Academic Paper
Linda's Manchester RMC presentation
Gordon's Presentation
Steve's Presentation
Subscribe to:
Posts (Atom)
person to visit this blog!!